Top Biotechnology Startups in 2024

Semaphore Solutions is a Canadian software company that supports the software engineering needs of clinical genomics laboratories across Europe and North America. Our clients are cutting-edge laboratories using next-generation sequencing (NGS) technologies to provide critical medical services, customer-direct services, and research. Labbit is the brainchild of Semaphore. We’re a team of 65 informatics experts with a long history of supporting laboratories with LIMS implementation, customization and custom software. We aim to advance global health by enabling the rapid implementation and iteration of innovative diagnostics and therapies. We do this with Labbit, the next-generation LIMS that lets you accelerate innovation cycles and scale faster.

10x Genomics (NASDAQ: TXG) is one of the fastest growing biotech companies, growing from $3M in revenue in 2015 to $240M in 2019. We create hardware, chemistry, and software that accelerates biological research. Our products are used by scientists around the world, including 96 of the top 100 global research institutions. Our mission is to build products that will be used throughout the rest of this century, to better understand, and eventually conquer disease. Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the diversity of the communities and the goals that we serve. The discoveries we make now, as a team, will lead to better technologies, better treatments, and a better future.

Ganymede is the first PaaS for biotech software engineering. Quickly integrate apps, import data, or design pipelines using a powerful bio-aware low-code platform.

Science develops advanced technologies with the goal to, over time, blur the line between medical devices and consumer electronics. Today we are focused on debilitating conditions for which there is a serious unmet medical need. As these technologies mature, they hold the potential to profoundly reshape the human condition.

There are currently four proprietary platforms, SmartCube®, NeuroCube®, PhenoCube® and eCube™. Using these platforms PsychoGenics can screen tens of thousands of compounds for CNS activity and identify those with a behavioral/physiological profile that reverses a disease model phenotype or that are similar to drugs that treat a specific neuropsychiatric disorder. The company’s technologies are being applied to discover treatments for psychiatric, cognitive, neurodegenerative, and seizure disorders, and pain. We partner and provide services to biotech, pharma, and non-profit organizations interested in developing new treatments.

Genomics is transforming medicine but data analysis and interpretation are the biggest bottlenecks. Basepair’s mission is for scientists, physicians, and ultimately people to extract actionable insights from genomic data to help with healthcare research, drug discovery, and personal health decisions. Basepair is an enterprise B2B SaaS for analytics and visualization of genomics data. Our customers include biopharma, molecular diagnostics, services, and some of the world’s top medical hospitals, e.g., Harvard Medical School, Stanford Univ, etc. We are funded by VCs, angel investors and have a front-row seat for the latest breakthroughs in life sciences.

Neuralink is developing a fully-implanted, wireless, high-channel count brain-machine interface (BMI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease. Neuralink was founded in 2016 by Elon Musk and the company is headquartered in Fremont, CA with a second location opening in Austin, TX.

Eli is a women's health company on a mission to improve lifelong health through continuous hormone monitoring. Hormones impact physical and mental health every day and at every stage of life. Eli offers real-time insights from hormones in saliva that can be tracked continuously over time, unlike traditional testing methods or send-out tests that only provide a single snapshot. With just three simple steps, Eli's at-home technology provides women with personalized hormone profiles to make informed decisions about their health. Eli is filling a data gap to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions. Eli has raised a total of $9 million so women can have the information they need to optimize their overall health from puberty to beyond menopause.

PureTech Health is a cross-disciplinary biotech company focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastro-intestinal and immune systems, and the interactions between them. PureTech has approximately 20 studies across its pipeline targeting multi-billion dollar market opportunities, including 5 human proof-of-concept and multiple pivotal or registration study readouts expected in the next 2 years. While inevitably some technologies will not advance to commercialization, PureTech’s approach mitigates risk as most of the cash resides on a PureTech parent company level, allowing PureTech to build value and divert cash to its most successful programs as milestones are achieved. PureTech has over 220 patents and applications. Its leading team and board, along with an advisory network of more than 60 scientists and advisors, gives PureTech access to potentially ground-breaking science.